ZURA
Zura Bio Limited Class A Ordinary Shares
NASDAQ: ZURA · HEALTHCARE · BIOTECHNOLOGY
$5.08
+1.40% today
Updated 2026-04-30
Market cap
$502.87M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.06
Dividend yield
—
52W range
$1 – $7
Volume
0.6M
Zura Bio Limited Class A Ordinary Shares (ZURA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | — | — | — | $9000.00 | $49000.00 |
| Gross profit | — | — | — | $-9000.00 | $-49000.00 |
| Gross margin | — | — | — | — | — |
| R&D | — | $23.69M | $44.00M | $24.40M | $42.08M |
| SG&A | — | $3.47M | $18.64M | $30.79M | $33.16M |
| Operating income | $-1.09M | $-27.16M | $-62.64M | $-55.19M | $-75.25M |
| Operating margin | — | — | — | — | — |
| EBITDA | $8.42M | $-27.16M | $-62.64M | $-55.18M | $-75.25M |
| EBITDA margin | — | — | — | — | — |
| EBIT | $8.42M | $-27.33M | $-60.56M | $-55.19M | — |
| Interest expense | — | — | — | — | — |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $8.42M | $-25.74M | $-60.36M | $-52.40M | $-99.35M |
| Net income growth (YoY) | — | -405.8% | -134.5% | +13.2% | -89.6% |
| Profit margin | — | — | — | — | — |